Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:beta-D-galactose
go back to main search page
Accession:CHEBI:27667 term browser browse the term
Definition:A D-galactopyranose having beta-configuration at the anomeric centre.
Synonyms:related_synonym: Formula=C6H12O6;   Gal-beta;   InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6-/m1/s1;   InChIKey=WQZGKKKJIJFFOK-FPRJBGLDSA-N;   SMILES=OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O;   beta-D-Gal;   beta-D-Galactopyranose
 alt_id: CHEBI:10383;   CHEBI:22774;   CHEBI:42776;   CHEBI:42889
 xref: Beilstein:1680744;   CAS:7296-64-2;   FooDB:FDB021788;   GlyTouCan:G65889KE;   Gmelin:648639;   HMDB:HMDB0003449;   KEGG:C00962;   MetaCyc:GALACTOSE;   PDBeChem:GAL;   PMID:17991151;   PMID:18619283;   PMID:19443021;   PMID:25568069;   PMID:31537530;   Reaxys:1680744
 cyclic_relationship: is_enantiomer_of CHEBI:37620


show annotations for term's descendants           Sort by:
 
4-methylumbelliferyl beta-D-galactoside term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ca12 carbonic anhydrase 12 decreases activity ISO 4-methylumbelliferyl-galactopyranoside analog results in decreased activity of CA12 protein CTD PMID:22077347 NCBI chr 8:72,405,770...72,461,425
Ensembl chr 8:72,405,748...72,460,240
JBrowse link
G Ca9 carbonic anhydrase 9 decreases activity ISO 4-methylumbelliferyl-galactopyranoside analog results in decreased activity of CA9 protein CTD PMID:22077347 NCBI chr 5:59,008,277...59,015,535
Ensembl chr 5:59,008,933...59,015,528
JBrowse link
kaempferol 3-O-beta-D-galactoside term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Pla2g2a phospholipase A2 group IIA affects activity ISO kaempferol-3-O-galactoside affects the activity of PLA2G2A protein CTD PMID:8190018 NCBI chr 5:157,282,650...157,285,295
Ensembl chr 5:157,282,669...157,285,328
JBrowse link
quercetin 3-O-beta-D-galactopyranoside term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase increases expression
multiple interactions
EXP hyperoside results in increased expression of ACHE mRNA
hyperoside results in increased expression of and results in increased activity of ACHE protein
CTD PMID:27019979 NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO
EXP
hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of BAX protein]
hyperoside inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein]
CTD PMID:18552516, PMID:31326407 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions EXP hyperoside inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:31326407 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions ISO [Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 protein CTD PMID:24173369 NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
JBrowse link
G Casp3 caspase 3 multiple interactions ISO [Quercetin co-treated with hyperoside] results in increased cleavage of CASP3 protein CTD PMID:24173369, PMID:25354548 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Cat catalase multiple interactions EXP cyclopamine inhibits the reaction [hyperoside inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein]]; hyperoside inhibits the reaction [Hydrogen Peroxide results in decreased activity of CAT protein] CTD PMID:31326407 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
JBrowse link
G Cycs cytochrome c, somatic multiple interactions ISO hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of CYCS protein] CTD PMID:18552516 NCBI chr 4:80,331,226...80,333,326
Ensembl chr 4:80,331,227...80,333,326
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases activity
multiple interactions
ISO hyperoside results in decreased activity of CYP2E1 protein
hyperoside inhibits the reaction [Acetaminophen results in decreased activity of CYP2E1 protein]
CTD PMID:26772156 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO hyperoside inhibits the reaction [Estradiol results in increased activity of ESR1 protein] CTD PMID:22613215 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
JBrowse link
G Gli1 GLI family zinc finger 1 multiple interactions
increases expression
EXP hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of GLI1 mRNA]; hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of GLI1 protein]
hyperoside results in increased expression of GLI1 mRNA; hyperoside results in increased expression of GLI1 protein
CTD PMID:31326407 NCBI chr 7:70,620,794...70,633,171
Ensembl chr 7:70,620,766...70,630,338
JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions ISO hyperoside inhibits the reaction [Acetaminophen results in increased activity of GPT protein] CTD PMID:26772156 NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein] CTD PMID:30125551 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein] CTD PMID:30125551 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Mir21 microRNA 21 multiple interactions ISO [Quercetin co-treated with hyperoside] results in decreased expression of MIR21 mRNA; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 mRNA]; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein]; MIR21 mRNA results in decreased susceptibility to [Quercetin co-treated with hyperoside] CTD PMID:25354548 NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
JBrowse link
G Mir27a microRNA 27a multiple interactions ISO [Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in decreased expression of ZBTB10 mRNA]; [Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in increased expression of SP1 mRNA]; [Quercetin co-treated with hyperoside] results in decreased expression of MIR27A mRNA; MIR27A mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of ZBTB10 mRNA] CTD PMID:24173369 NCBI chr19:25,318,736...25,318,822
Ensembl chr19:25,318,736...25,318,822
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 affects localization ISO hyperoside affects the localization of NFE2L2 protein CTD PMID:26772156 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] CTD PMID:30125551 NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression EXP Hyperoside increases expression of Nqo1 protein in liver RGD PMID:31399183 RGD:25823190 NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO [Quercetin co-treated with hyperoside] results in increased cleavage of PARP1 protein CTD PMID:24173369, PMID:25354548 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
JBrowse link
G Pdcd4 programmed cell death 4 multiple interactions ISO [Quercetin co-treated with hyperoside] results in increased expression of PDCD4 mRNA; [Quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 mRNA]; MIR21 mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of PDCD4 protein] CTD PMID:25354548 NCBI chr 1:274,616,625...274,648,204
Ensembl chr 1:274,625,224...274,648,204
JBrowse link
G Prima1 proline rich membrane anchor 1 increases expression EXP hyperoside results in increased expression of PRIMA1 mRNA CTD PMID:27019979 NCBI chr 6:127,075,954...127,127,985
Ensembl chr 6:127,075,954...127,127,413
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein] CTD PMID:30125551 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
JBrowse link
G Shh sonic hedgehog signaling molecule increases expression
multiple interactions
EXP hyperoside results in increased expression of SHH mRNA; hyperoside results in increased expression of SHH protein
hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SHH mRNA]; hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SHH protein]
CTD PMID:31326407 NCBI chr 4:718,538...727,691
Ensembl chr 4:718,538...727,691
JBrowse link
G Sirt1 sirtuin 1 multiple interactions ISO hyperoside inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SIRT1 protein] CTD PMID:18552516 NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
JBrowse link
G Smo smoothened, frizzled class receptor increases expression
multiple interactions
EXP hyperoside results in increased expression of SMO mRNA; hyperoside results in increased expression of SMO protein
hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO mRNA]; hyperoside promotes the reaction [Hydrogen Peroxide results in increased expression of SMO protein]
CTD PMID:31326407 NCBI chr 4:57,019,941...57,041,779
Ensembl chr 4:57,019,941...57,042,770
JBrowse link
G Sp1 Sp1 transcription factor multiple interactions ISO [Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in increased expression of SP1 mRNA]; [Quercetin co-treated with hyperoside] results in decreased expression of SP1 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of SP1 protein CTD PMID:24173369 NCBI chr 7:144,014,173...144,044,635
Ensembl chr 7:144,014,173...144,044,629
JBrowse link
G Sp3 Sp3 transcription factor multiple interactions ISO [Quercetin co-treated with hyperoside] results in decreased expression of SP3 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of SP3 protein CTD PMID:24173369 NCBI chr 3:59,644,579...59,689,011
Ensembl chr 3:59,646,015...59,688,692
JBrowse link
G Sp4 Sp4 transcription factor multiple interactions ISO [Quercetin co-treated with hyperoside] results in decreased expression of SP4 mRNA; [Quercetin co-treated with hyperoside] results in decreased expression of SP4 protein CTD PMID:24173369 NCBI chr 6:146,135,877...146,201,344
Ensembl chr 6:146,135,877...146,195,819
JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 multiple interactions ISO hyperoside inhibits the reaction [Acetaminophen results in decreased expression of SULT1A1 mRNA] CTD PMID:26772156 NCBI chr 1:198,100,586...198,104,106
Ensembl chr 1:198,100,586...198,104,109
JBrowse link
G Sult2a1 sulfotransferase family 2A member 1 multiple interactions
increases expression
ISO hyperoside inhibits the reaction [Acetaminophen results in decreased expression of SULT2A1 mRNA]
hyperoside results in increased expression of SULT2A1 mRNA
CTD PMID:26772156 NCBI chr 1:76,558,721...76,614,315
Ensembl chr 1:76,252,329...76,780,230
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO hyperoside inhibits the reaction [TNF protein results in increased expression of TNFRSF1A protein]; hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; hyperoside inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein] CTD PMID:30125551 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Tnfrsf1a TNF receptor superfamily member 1A multiple interactions ISO hyperoside inhibits the reaction [TNF protein results in increased expression of TNFRSF1A protein] CTD PMID:30125551 NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 multiple interactions
increases expression
ISO hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT1A1 mRNA]
hyperoside results in increased expression of UGT1A1 mRNA
CTD PMID:26772156 NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
JBrowse link
G Ugt1a6 UDP glucuronosyltransferase family 1 member A6 multiple interactions ISO hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT1A6 mRNA] CTD PMID:26772156 NCBI chr 9:95,241,609...95,302,822
Ensembl chr 9:95,161,157...95,302,822
JBrowse link
G Ugt2b17 UDP glucuronosyltransferase family 2 member B17 multiple interactions
increases expression
ISO hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA]
hyperoside results in increased expression of UGT2B1 mRNA
CTD PMID:26772156 NCBI chr14:22,724,399...22,736,148
Ensembl chr14:22,724,070...22,825,444
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]; hyperoside inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] CTD PMID:30125551 NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
JBrowse link
G Zbtb10 zinc finger and BTB domain containing 10 multiple interactions ISO [Quercetin co-treated with hyperoside] inhibits the reaction [MIR27A mRNA results in decreased expression of ZBTB10 mRNA]; [Quercetin co-treated with hyperoside] results in increased expression of ZBTB10 mRNA; MIR27A mRNA inhibits the reaction [[Quercetin co-treated with hyperoside] results in increased expression of ZBTB10 mRNA] CTD PMID:24173369 NCBI chr 2:94,692,939...94,730,976
Ensembl chr 2:94,692,939...94,730,978
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19792
    role 19738
      biological role 19737
        epitope 6841
          beta-D-galactose 40
            2-amino-2-deoxy-beta-D-galactopyranose 0
            2-deoxy-2-fluoro-beta-D-galactose 0
            3-O-sulfo-beta-D-galactose + 0
            alpha-D-Glcp-(1->3)-beta-D-Galp + 0
            alpha-D-Glcp-(1->4)-beta-D-Galp + 0
            alpha-D-Glcp-(1->6)-beta-D-Galp 0
            alpha-D-Manp-(1->3)-beta-D-Galp 0
            alpha-D-Manp-(1->6)-beta-D-Galp 0
            alpha-L-Arap-(1->3)-beta-D-Galp 0
            alpha-L-Fucp-(1->6)-beta-D-Galp 0
            beta-D-Galf-(1->4)-alpha-D-Galp 0
            beta-D-Galp-(1->2)-D-Galp 0
            beta-D-Galp-(1->2)-D-Glcp + 0
            beta-D-Galp-(1->2)-alpha-D-Glcp 0
            beta-D-Galp-(1->2)-beta-D-Glcp 0
            beta-D-Galp-(1->3)-D-GlcpN 0
            beta-D-Galp-(1->3)-D-Manp 0
            beta-D-Galp-(1->3)-GalNAc-OH 0
            beta-D-Galp-(1->3)-L-Araf + 0
            beta-D-Galp-(1->3)-Man-OH 0
            beta-D-Galp-(1->3)-alpha-D-Glcp 0
            beta-D-Galp-(1->3)-alpha-D-GlcpNAc 0
            beta-D-Galp-(1->3)-alpha-L-Araf 0
            beta-D-Galp-(1->3)-beta-D-Xylp 0
            beta-D-Galp-(1->4)-D-Gal-OH 0
            beta-D-Galp-(1->4)-D-ManpNAc 0
            beta-D-Galp-(1->4)-D-Xylp + 0
            beta-D-Galp-(1->4)-alpha-L-Fucp 0
            beta-D-Galp-(1->4)-beta-D-GalpNAc 0
            beta-D-Galp-(1->6)-D-Gal-OH 0
            beta-D-Galp-(1->6)-D-Galf + 0
            beta-D-Galp-(1->6)-D-GalpNAc 0
            beta-D-Galp-(1->6)-D-Manp + 0
            beta-D-Galp-(1->6)-alpha-D-GlcpNAc 0
            beta-D-Galp-(1->6)-alpha-D-Manp 0
            beta-D-GalpNAc-(1->4)-beta-D-Galp 0
            beta-D-Glcp(1->2)-[beta-D-Glcp-(1->3)]-beta-D-Galp 0
            beta-D-Glcp-(1->3)-beta-D-Galp 0
            beta-D-Glcp-(1->4)-D-Galp + 0
            beta-D-Glcp-(1->4)-beta-D-Galp 0
            beta-D-Glcp-(1->4)-beta-D-Glcp-(1->4)-beta-D-Galp 0
            beta-D-Glcp-(1->6)-beta-D-Galp 0
            beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-beta-D-Galp 0
            beta-D-GlcpNAc-(1->2)-beta-D-Galp 0
            beta-D-GlcpNAc-(1->4)-beta-D-Galp + 0
            beta-D-GlcpNAc-(1->6)-beta-D-Galp + 0
            beta-D-galactopyranosyl D-galactopyranoside 0
            beta-D-galactoside + 40
            beta-D-galactosyl groups + 0
            beta-L-Fucp-(1->2)-beta-D-Galp 0
            beta-epilactose 0
            isorhamnetin 3-O-beta-D-galactopyranoside 0
            myricetin 3-O-beta-D-galactopyranoside 0
            oceanalin A 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19792
    subatomic particle 19788
      composite particle 19788
        hadron 19788
          baryon 19788
            nucleon 19788
              atomic nucleus 19788
                atom 19788
                  main group element atom 19675
                    p-block element atom 19675
                      carbon group element atom 19571
                        carbon atom 19560
                          organic molecular entity 19560
                            heteroorganic entity 19165
                              organochalcogen compound 18873
                                organooxygen compound 18795
                                  carbohydrates and carbohydrate derivatives 12193
                                    carbohydrate 12193
                                      monosaccharide 4024
                                        aldose 2540
                                          aldohexose 2186
                                            D-aldohexose 2180
                                              D-galactose 164
                                                D-galactopyranose 164
                                                  beta-D-galactose 40
                                                    2-amino-2-deoxy-beta-D-galactopyranose 0
                                                    2-deoxy-2-fluoro-beta-D-galactose 0
                                                    3-O-sulfo-beta-D-galactose + 0
                                                    alpha-D-Glcp-(1->3)-beta-D-Galp + 0
                                                    alpha-D-Glcp-(1->4)-beta-D-Galp + 0
                                                    alpha-D-Glcp-(1->6)-beta-D-Galp 0
                                                    alpha-D-Manp-(1->3)-beta-D-Galp 0
                                                    alpha-D-Manp-(1->6)-beta-D-Galp 0
                                                    alpha-L-Arap-(1->3)-beta-D-Galp 0
                                                    alpha-L-Fucp-(1->6)-beta-D-Galp 0
                                                    beta-D-Galf-(1->4)-alpha-D-Galp 0
                                                    beta-D-Galp-(1->2)-D-Galp 0
                                                    beta-D-Galp-(1->2)-D-Glcp + 0
                                                    beta-D-Galp-(1->2)-alpha-D-Glcp 0
                                                    beta-D-Galp-(1->2)-beta-D-Glcp 0
                                                    beta-D-Galp-(1->3)-D-GlcpN 0
                                                    beta-D-Galp-(1->3)-D-Manp 0
                                                    beta-D-Galp-(1->3)-GalNAc-OH 0
                                                    beta-D-Galp-(1->3)-L-Araf + 0
                                                    beta-D-Galp-(1->3)-Man-OH 0
                                                    beta-D-Galp-(1->3)-alpha-D-Glcp 0
                                                    beta-D-Galp-(1->3)-alpha-D-GlcpNAc 0
                                                    beta-D-Galp-(1->3)-alpha-L-Araf 0
                                                    beta-D-Galp-(1->3)-beta-D-Xylp 0
                                                    beta-D-Galp-(1->4)-D-Gal-OH 0
                                                    beta-D-Galp-(1->4)-D-ManpNAc 0
                                                    beta-D-Galp-(1->4)-D-Xylp + 0
                                                    beta-D-Galp-(1->4)-alpha-L-Fucp 0
                                                    beta-D-Galp-(1->4)-beta-D-GalpNAc 0
                                                    beta-D-Galp-(1->6)-D-Gal-OH 0
                                                    beta-D-Galp-(1->6)-D-Galf + 0
                                                    beta-D-Galp-(1->6)-D-GalpNAc 0
                                                    beta-D-Galp-(1->6)-D-Manp + 0
                                                    beta-D-Galp-(1->6)-alpha-D-GlcpNAc 0
                                                    beta-D-Galp-(1->6)-alpha-D-Manp 0
                                                    beta-D-GalpNAc-(1->4)-beta-D-Galp 0
                                                    beta-D-Glcp(1->2)-[beta-D-Glcp-(1->3)]-beta-D-Galp 0
                                                    beta-D-Glcp-(1->3)-beta-D-Galp 0
                                                    beta-D-Glcp-(1->4)-D-Galp + 0
                                                    beta-D-Glcp-(1->4)-beta-D-Galp 0
                                                    beta-D-Glcp-(1->4)-beta-D-Glcp-(1->4)-beta-D-Galp 0
                                                    beta-D-Glcp-(1->6)-beta-D-Galp 0
                                                    beta-D-Glcp-(1->6)-beta-D-Glcp-(1->6)-beta-D-Galp 0
                                                    beta-D-GlcpNAc-(1->2)-beta-D-Galp 0
                                                    beta-D-GlcpNAc-(1->4)-beta-D-Galp + 0
                                                    beta-D-GlcpNAc-(1->6)-beta-D-Galp + 0
                                                    beta-D-galactopyranosyl D-galactopyranoside 0
                                                    beta-D-galactoside + 40
                                                    beta-D-galactosyl groups + 0
                                                    beta-L-Fucp-(1->2)-beta-D-Galp 0
                                                    beta-epilactose 0
                                                    isorhamnetin 3-O-beta-D-galactopyranoside 0
                                                    myricetin 3-O-beta-D-galactopyranoside 0
                                                    oceanalin A 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.